Effect of Comorbidities on Ten-Year Survival in Patients with Dementia.

BACKGROUND There is a verified association between comorbidity and survival in patients with dementia. OBJECTIVE To describe the ten-year survival probability of patients with dementia and to identify the impact of comorbidity. METHODS The prognostic retrospective cohort study was conducted using data from adults with dementia who had visited the outpatient departments at Maharaj Nakorn Chiang Mai hospital between 2006 and 2012. Dementia was verified in accordance with standard practice guidelines. Secondary data detailing about patient age, gender, date of dementia diagnosis and death, types of dementia, and comorbidities at the time of dementia diagnosis was obtained from electronic medical records. The association between comorbidity, patients' underlying disease at dementia diagnosis, and overall survival were analyzed using a multivariable Cox proportional hazard model adjusted for age, gender, types of dementia, and other comorbidities. RESULTS Of the 702 patients, 56.9% were female. Alzheimer's disease (39.6%) was the most prevalent type of dementia. Median overall survival was 6.0 years (95% CI 5.5- 6.7). The comorbidities associated with a high risk of mortality included liver disease (aHR 2.70, 95% CI 1.46- 5.00), atrial fibrillation (aHR 2.15, 95% CI 1.29- 3.58), myocardial infarction (aHR 1.55, 95% CI 1.07- 2.26), and type 2 diabetes mellitus (aHR 1.40, 95% CI 1.13- 1.74). CONCLUSION Overall survival rate of patients with dementia in Thailand was comparable to previous studies. Several comorbidities were associated with a ten-year survival. The prognosis of patients with dementia may be improved by appropriate care of comorbidities.

[1]  Á. Alonso,et al.  Associations of Atrial Fibrillation with Mild Cognitive Impairment and Dementia: An Investigation Using SPRINT Research Materials , 2022, Journal of clinical medicine.

[2]  H. Hagström,et al.  Nonalcoholic Fatty Liver Disease and Risk of Dementia , 2022, Neurology.

[3]  D. Giunta,et al.  [Mortality in patients with dementia admitted in critical care units]. , 2022, Revista espanola de geriatria y gerontologia.

[4]  Sang Min Park,et al.  Association of non-alcoholic fatty liver disease with incident dementia later in life among elder adults , 2022, Clinical and molecular hepatology.

[5]  Spiros C. Denaxas,et al.  Incidence, morbidity, mortality and disparities in dementia: A population linked electronic health records study of 4.3 million individuals , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[6]  I. Oh,et al.  Association between non‐alcoholic fatty liver disease and the risk of dementia: A nationwide cohort study , 2022, Liver international : official journal of the International Association for the Study of the Liver.

[7]  C. Suemoto,et al.  Accuracy of two prognostic indexes to predict mortality in older adults with advanced dementia , 2022, Dementia & neuropsychologia.

[8]  E. Kang,et al.  Severe Hypoglycemia Increases Dementia Risk and Related Mortality: A Nationwide, Population-Based Cohort Study. , 2022, The Journal of clinical endocrinology and metabolism.

[9]  Yongliang Gao,et al.  Secular Trends in the Incidence of and Mortality Due to Alzheimer’s Disease and Other Forms of Dementia in China From 1990 to 2019: An Age-Period-Cohort Study and Joinpoint Analysis , 2021, Frontiers in Aging Neuroscience.

[10]  Wenli Zhang,et al.  Relationship between multimorbidity, disease cluster and all-cause mortality among older adults: a retrospective cohort analysis , 2021, BMC Public Health.

[11]  B. Winblad,et al.  Mortality After Ischemic Stroke in Patients with Alzheimer’s Disease Dementia and Other Dementia Disorders , 2021, Journal of Alzheimer's disease : JAD.

[12]  H. Brodaty,et al.  Dementia increases mortality beyond effects of comorbid conditions: A national registry‐based cohort study , 2021, European journal of neurology.

[13]  Kankamol Jaisin,et al.  Etiology of Dementia in Thai Patients , 2021, Dementia and Geriatric Cognitive Disorders Extra.

[14]  I. Hadžibegović,et al.  Patients with dementia and atrial fibrillation less frequently receive direct oral anticoagulants (DOACs) and experience higher thrombotic and mortality risk , 2021, Acta clinica Belgica.

[15]  S. Hartikainen,et al.  The effect of comorbidities on survival in persons with Alzheimer’s disease: a matched cohort study , 2021, BMC Geriatrics.

[16]  R. Stewart,et al.  Mortality rates in Alzheimer's disease and non-Alzheimer's dementias: a systematic review and meta-analysis. , 2021, The Lancet. Healthy longevity.

[17]  Jose A. Santiago,et al.  The Impact of Disease Comorbidities in Alzheimer's Disease , 2021, Frontiers in Aging Neuroscience.

[18]  Tanyaluk O. Bunlikitkul,et al.  Atrial fibrillation prevalence and risk profile from novel community-based screening in Thailand: A prospective multi-centre study , 2021, International journal of cardiology. Heart & vasculature.

[19]  B. Winblad,et al.  Calcium channel blockers, survival and ischaemic stroke in patients with dementia: a Swedish registry study , 2020, Journal of internal medicine.

[20]  M. Prince,et al.  Mortality Rates and Mortality Risk Factors in Older Adults with Dementia from Low- and Middle-Income Countries: The 10/66 Dementia Research Group Population-Based Cohort Study , 2020, Journal of Alzheimer's disease : JAD.

[21]  L. Tan,et al.  The Prevalence of Dementia: A Systematic Review and Meta-Analysis. , 2019, Journal of Alzheimer's disease : JAD.

[22]  Ming-Chin Lin,et al.  Association Between Atrial Fibrillation and Dementia: A Meta-Analysis , 2019, Front. Aging Neurosci..

[23]  David A Bennett,et al.  Diagnosis and Management of Dementia: Review. , 2019, JAMA.

[24]  J. Vilalta-Franch,et al.  Survival, effect measures, and impact numbers after dementia diagnosis: a matched cohort study , 2019, Clinical epidemiology.

[25]  Ming-Tsang Wu,et al.  Association of hyperglycemia episodes on long-term mortality in type 2 diabetes mellitus with vascular dementia: A population-based cohort study. , 2019, Journal of diabetes and its complications.

[26]  L. Schneider,et al.  Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need , 2018, Alzheimer's & Dementia.

[27]  O. Sinanović,et al.  Communication Difficulties as a Result of Dementia , 2018, Materia socio-medica.

[28]  G. Selbæk,et al.  Survival and years of life lost in various aetiologies of dementia, mild cognitive impairment (MCI) and subjective cognitive decline (SCD) in Norway , 2018, PloS one.

[29]  C. Muo,et al.  Estimating the survival of elderly patients diagnosed with dementia in Taiwan: A longitudinal study , 2018, PloS one.

[30]  R. Howard,et al.  Diagnosed depression and sociodemographic factors as predictors of mortality in patients with dementia , 2018, The British journal of psychiatry : the journal of mental science.

[31]  Mostafa Rezaei-Tavirani,et al.  Protein-protein interaction analysis of Alzheimer`s disease and NAFLD based on systems biology methods unhide common ancestor pathways , 2018, Gastroenterology and hepatology from bed to bench.

[32]  J. Hardy,et al.  Alzheimer's disease , 2018, European journal of neurology.

[33]  E. Kang,et al.  Impact of diabetes mellitus and chronic liver disease on the incidence of dementia and all-cause mortality among patients with dementia , 2017, Medicine.

[34]  Tyler J. VanderWeele,et al.  Sensitivity Analysis in Observational Research: Introducing the E-Value , 2017, Annals of Internal Medicine.

[35]  Pei-Ning Wang,et al.  Comorbidity and dementia: A nationwide survey in Taiwan , 2017, PloS one.

[36]  David C. Atkins,et al.  Dementia and co‐occurring chronic conditions: a systematic literature review to identify what is known and where are the gaps in the evidence? , 2017, International journal of geriatric psychiatry.

[37]  R. Weinstock,et al.  Management of Adults With Diabetes and Cognitive Problems , 2016, Diabetes Spectrum.

[38]  M. Prince,et al.  Recent global trends in the prevalence and incidence of dementia, and survival with dementia , 2016, Alzheimer's Research & Therapy.

[39]  Leon E. Toussaint,et al.  Non-alcoholic fatty liver disease induces signs of Alzheimer’s disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model , 2016, Journal of Neuroinflammation.

[40]  J. Reitsma,et al.  Effect of Vascular Risk Factors and Diseases on Mortality in Individuals with Dementia: A Systematic Review and Meta‐Analysis , 2016, Journal of the American Geriatrics Society.

[41]  M. Barcikowska,et al.  Hypertension in patients with Alzheimer's disease--prevalence, characteristics, and impact on clinical outcome. Experience of one neurology center in Poland. , 2015, Journal of the American Society of Hypertension : JASH.

[42]  Ronald C Petersen,et al.  Multimorbidity and Risk of Mild Cognitive Impairment , 2015, Journal of the American Geriatrics Society.

[43]  R. Petersen,et al.  Risk and protective factors for cognitive impairment in persons aged 85 years and older , 2015, Neurology.

[44]  Michael E. Miller,et al.  The Cross-sectional and Longitudinal Associations of Diabetic Retinopathy With Cognitive Function and Brain MRI Findings: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial , 2014, Diabetes Care.

[45]  I. Rosset,et al.  Global Epidemiology of Dementia: Alzheimer's and Vascular Types , 2014, BioMed research international.

[46]  S. M. de la Monte,et al.  Brain metabolic dysfunction at the core of Alzheimer's disease. , 2014, Biochemical pharmacology.

[47]  J. Williamson,et al.  Albuminuria and cognitive decline in people with diabetes and normal renal function. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[48]  Stephen Todd,et al.  Survival in dementia and predictors of mortality: a review , 2013, International journal of geriatric psychiatry.

[49]  E. Sampson,et al.  Survival of people with dementia after unplanned acute hospital admission: a prospective cohort study , 2013, International journal of geriatric psychiatry.

[50]  J. Semmens,et al.  Earlier age of dementia onset and shorter survival times in dementia patients with diabetes. , 2013, American journal of epidemiology.

[51]  J. Mant,et al.  Thromboprophylaxis of elderly patients with AF in the UK: an analysis using the General Practice Research Database (GPRD) 2000–2009 , 2012, Heart.

[52]  I. Torres-Aleman,et al.  The many faces of insulin-like peptide signalling in the brain , 2012, Nature Reviews Neuroscience.

[53]  J. Leal,et al.  UK research expenditure on dementia, heart disease, stroke and cancer: are levels of spending related to disease burden? , 2012, European journal of neurology.

[54]  Silvio Garattini,et al.  Multiple diseases and polypharmacy in the elderly: challenges for the internist of the third millennium , 2011, Journal of comorbidity.

[55]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[56]  B. Winblad,et al.  Diabetes, Alzheimer disease, and vascular dementia , 2010, Neurology.

[57]  A. Levey,et al.  Factors Affecting Survival of Patients with Neurodegenerative Disease , 2010, Neuroepidemiology.

[58]  Y. Stern,et al.  Survival in Alzheimer disease , 2008, Neurology.

[59]  C. Bulpitt,et al.  Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial , 2008, The Lancet Neurology.

[60]  A. Blamire,et al.  Cognitive impairment in primary biliary cirrhosis: Symptom impact and potential etiology , 2008, Hepatology.

[61]  I. Poon Effects of Antihypertensive Drug Treatment on the Risk of Dementia and Cognitive Impairment , 2008, Pharmacotherapy.

[62]  G. Zielhuis,et al.  Prognosis and vascular co-morbidity in dementia a historical cohort study in general practice , 2008, The journal of nutrition, health & aging.

[63]  Jing Xie,et al.  Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up , 2008, BMJ : British Medical Journal.

[64]  E. Tolosa,et al.  Clinical diagnostic criteria for dementia associated with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[65]  Richard Mayeux,et al.  Relation of diabetes to mild cognitive impairment. , 2007, Archives of neurology.

[66]  H. Tillmann,et al.  Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment , 2006, Gut.

[67]  K Yaffe,et al.  Frontotemporal dementia progresses to death faster than Alzheimer disease , 2005, Neurology.

[68]  Werner Poewe,et al.  How to diagnose dementia with Lewy bodies: State of the art , 2005, Movement disorders : official journal of the Movement Disorder Society.

[69]  S. DeKosky,et al.  Alzheimer disease and mortality: a 15-year epidemiological study. , 2005, Archives of neurology.

[70]  H. Tillmann,et al.  Hepatitis C virus infection and the brain , 2004, Metabolic Brain Disease.

[71]  W. Kukull,et al.  Survival after Initial Diagnosis of Alzheimer Disease , 2004, Annals of Internal Medicine.

[72]  K. Schulman,et al.  The Effect of Dementia on Outcomes and Process of Care for Medicare Beneficiaries Admitted with Acute Myocardial Infarction , 2004, Journal of the American Geriatrics Society.

[73]  P. K. Gangopadhaya,et al.  Parkinsonism plus syndrome--a review. , 2003, Neurology India.

[74]  L. Launer,et al.  Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. , 2002, Diabetes.

[75]  B Miller,et al.  Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. , 2001, Archives of neurology.

[76]  J. Allsop,et al.  Evidence for a cerebral effect of the hepatitis C virus , 2001, The Lancet.

[77]  T Ostbye,et al.  A reevaluation of the duration of survival after the onset of dementia. , 2001, The New England journal of medicine.

[78]  S. Weyerer,et al.  Predictors of mortality among demented elderly in primary care , 1999, International journal of geriatric psychiatry.

[79]  B. Winblad,et al.  Mortality from dementia in advanced age: a 5-year follow-up study of incident dementia cases. , 1999, Journal of clinical epidemiology.

[80]  B. Winblad,et al.  Prognostic Factors in Very Old Demented Adults: A Seven‐Year Follow‐Up From a Population‐Based Survey in Stockholm , 1998, Journal of the American Geriatrics Society.

[81]  J. H. van der Meulen,et al.  Comorbidity and Its Effect on Mortality in Nursing Home Patients with Dementia , 1996, The Journal of nervous and mental disease.

[82]  C. Pieper,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XIV , 1996, Neurology.

[83]  P. Mölsä,et al.  Long‐term survival and predictors of mortality in Alzheimer's disease and multi‐infarct dementia , 1995, Acta neurologica Scandinavica.

[84]  Amos D. Korczyn,et al.  Vascular dementia , 1993, Journal of the Neurological Sciences.

[85]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[86]  S. Monte Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer’s Disease , 2016, Drugs.

[87]  P. Rabins,et al.  Dementia , 2008, Annals of Internal Medicine.